Barclays Boosts Keurig Dr Pepper (NASDAQ:KDP) Price Target to $41.00

Keurig Dr Pepper (NASDAQ:KDP) had its price objective lifted by Barclays from $37.00 to $41.00 in a report released on Friday, Benzinga reports. They currently have an overweight rating on the stock.

KDP has been the topic of a number of other research reports. Royal Bank of Canada reiterated an outperform rating and issued a $41.00 price target on shares of Keurig Dr Pepper in a research report on Friday, July 26th. TD Cowen boosted their price target on Keurig Dr Pepper from $35.00 to $40.00 and gave the company a hold rating in a research note on Thursday, September 26th. Citigroup upgraded shares of Keurig Dr Pepper from a neutral rating to a buy rating and boosted their target price for the company from $36.00 to $43.00 in a research report on Monday, September 23rd. JPMorgan Chase & Co. reduced their price target on shares of Keurig Dr Pepper from $37.00 to $36.00 and set an overweight rating for the company in a report on Wednesday, July 10th. Finally, Deutsche Bank Aktiengesellschaft upped their price objective on shares of Keurig Dr Pepper from $36.00 to $37.00 and gave the company a hold rating in a report on Monday, September 23rd. Seven analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of Moderate Buy and an average price target of $37.86.

Keurig Dr Pepper Stock Performance

Shares of KDP stock opened at $36.65 on Friday. The business’s 50-day moving average price is $36.47 and its 200-day moving average price is $34.32. Keurig Dr Pepper has a 12 month low of $27.81 and a 12 month high of $38.28. The company has a current ratio of 0.51, a quick ratio of 0.34 and a debt-to-equity ratio of 0.50. The firm has a market capitalization of $49.68 billion, a price-to-earnings ratio of 23.65, a PEG ratio of 2.73 and a beta of 0.62.

Keurig Dr Pepper (NASDAQ:KDP) last announced its quarterly earnings results on Thursday, July 25th. The company reported $0.45 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.45. The firm had revenue of $3.92 billion during the quarter, compared to analysts’ expectations of $3.91 billion. Keurig Dr Pepper had a net margin of 14.47% and a return on equity of 10.32%. The company’s revenue was up 3.5% on a year-over-year basis. During the same period in the prior year, the company posted $0.42 EPS. Equities research analysts forecast that Keurig Dr Pepper will post 1.92 EPS for the current year.

Keurig Dr Pepper Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, October 11th. Investors of record on Friday, September 27th were given a dividend of $0.23 per share. This is a boost from Keurig Dr Pepper’s previous quarterly dividend of $0.22. The ex-dividend date of this dividend was Friday, September 27th. This represents a $0.92 annualized dividend and a dividend yield of 2.51%. Keurig Dr Pepper’s payout ratio is presently 59.35%.

Institutional Trading of Keurig Dr Pepper

Several institutional investors have recently made changes to their positions in the company. Price T Rowe Associates Inc. MD boosted its position in Keurig Dr Pepper by 107.6% in the first quarter. Price T Rowe Associates Inc. MD now owns 23,654,577 shares of the company’s stock worth $725,487,000 after purchasing an additional 12,259,471 shares during the last quarter. Vanguard Group Inc. raised its position in Keurig Dr Pepper by 9.4% in the first quarter. Vanguard Group Inc. now owns 90,840,391 shares of the company’s stock worth $2,786,075,000 after acquiring an additional 7,825,418 shares during the period. Dimensional Fund Advisors LP boosted its stake in Keurig Dr Pepper by 41.8% in the second quarter. Dimensional Fund Advisors LP now owns 6,373,362 shares of the company’s stock valued at $212,901,000 after acquiring an additional 1,878,597 shares during the last quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH purchased a new stake in shares of Keurig Dr Pepper during the 2nd quarter worth approximately $37,643,000. Finally, Armistice Capital LLC increased its stake in shares of Keurig Dr Pepper by 186.3% during the 2nd quarter. Armistice Capital LLC now owns 1,486,063 shares of the company’s stock worth $49,635,000 after purchasing an additional 966,924 shares during the last quarter. Institutional investors own 85.23% of the company’s stock.

Keurig Dr Pepper Company Profile

Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.